<DOC>
	<DOCNO>NCT01649427</DOCNO>
	<brief_summary>The purpose study investigate Tacrolimus Hexal速 similar pharmacokinetic property compare Prograf速 de novo renal transplant patient whether comparable exposure result similar renal function .</brief_summary>
	<brief_title>Comparison Tacrolimus Hexal速 Based Regimen Versus Prograf速 Based Regimen de Novo Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Inclusion : primary sec . kidney transplant patiens , write consent , cold ischemia &lt; 24 h Exclusion : multi organ , immunological risc pts. , PRA &gt; 20 % , Antibodys HLAtype donor organ , hypersensitivity Tacro MMF , Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pharmacokinetics Study</keyword>
	<keyword>Tacroliums</keyword>
	<keyword>GFR</keyword>
	<keyword>kdney</keyword>
</DOC>